Vaccine maker $NVAX Novavax plans to reduce its total global workforce by about 12% to cut costs. Given the reported results, I understand the move, and I wonder if it will help them dig out of the red when the approval of a new covid vaccine didn't.
I also read this somewhere and it's good news, I'm still holding them but it's a big misery and Covid is passé already, I hope they somehow mobilize and come up with something to bounce back on, otherwise I think they're going to declare bankruptcy.